Live Breaking News & Updates on டீன் ரேண்டால்ஃப்

Stay updated with breaking news from டீன் ரேண்டால்ஃப். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

PDS Biotech Provides Business Update and Reports First Quarter 2021 Financial Results


PDS Biotech Provides Business Update and Reports First Quarter 2021 Financial Results
Nachrichtenquelle: globenewswire
 |  13.05.2021, 13:00  | 
43 
 | 

FLORHAM PARK, N.J., May 13, 2021 (GLOBE NEWSWIRE) PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease
vaccines based on the Company’s proprietary Versamune T-cell activating technology, will discuss its financial results for the quarter ended March 31, 2021 and provide a business update on its
conference call today.
Recent Business Highlights:
National Cancer Institute to present interim efficacy and safety data of PDS0101 Phase 2 clinical trial in an oral presentation
at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting on June 7, 2021. ....

United States , Frank Bedu , Deanne Randolph , National Cancer Institute , American Society Of Clinical Oncology , Drug Administration , Biotechnology Corporation The Company , United States Securities Exchange , Ministry Of Science , American Society , Clinical Oncology , Bintrafusp Alfa , Scientific Training , Frank Bedu Addo , Chief Executive Officer , Versamunet Cell , United States Securities Exchange Act , States Securities Act , Investor Relations Contact , Consolidated Statements , Months Ended March , ஒன்றுபட்டது மாநிலங்களில் , வெளிப்படையான பேடு , டீன் ரேண்டால்ஃப் , தேசிய புற்றுநோய் நிறுவனம் , அமெரிக்கன் சமூகம் ஆஃப் மருத்துவ புற்றுநோயியல் ,

PDS Biotech Announces Presentation and Panel Participation at the Benzinga Biotech Small Cap Conference


PDS Biotech Announces Presentation and Panel Participation at the Benzinga Biotech Small Cap Conference
Florham Park, New Jersey (Newsfile Corp. - March 17, 2021) - PDS Biotechnology Corporation (NASDAQ: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company s proprietary Versamune® T-cell activating technology, today announced that Dr. Frank Bedu-Addo, CEO of PDS Biotech, will present the company s immunotherapy platform, ongoing phase 2 clinical programs, product pipeline and upcoming milestones virtually at the Benzinga Biotech Small Cap Conference on Wednesday, March 24 at 10:05 am ET. In addition, Dr. Bedu-Addo will participate in the Cancer Immunotherapies: Fighting Cancer with the power of the Immune System panel immediately following his presentation at 10:25am ET on Wednesday, March 24. ....

Jacob Goldberger , Frank Bedu , Deanne Randolph , Jersey Newsfile Corp , Biotechnology Corporation , Florham Park , Frank Bedu Addo , Benzinga Biotech Small Cap Conference , Fighting Cancer , Investor Relations Contact , ஜாகோப் கோல்ட்பர்கர் , வெளிப்படையான பேடு , டீன் ரேண்டால்ஃப் , உயிரி தொழில்நுட்பவியல் நிறுவனம் , புளோர்ஹாம் பூங்கா , வெளிப்படையான பேடு , சண்டை புற்றுநோய் , முதலீட்டாளர் உறவுகள் தொடர்பு ,